Apricell

Apricell Biotechnology Inc. is dedicated to reducing the attrition rate of new cancer drugs in clinical trials.  In collaboration with the University, Apricell has developed a novel Organoid-on-a-Plate technology that opens up multiple opportunities for researchers and oncologists all the way from basic research and drug testing to advanced patient management.

Learn more

Watch the videos

HTsphere plate New